Solid Biosciences Inc.
corporate_fare Company Profile
Solid Biosciences Inc. (NASDAQ:SLDB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for SLDB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- RA Capital Management Increases Stake in Solid Biosciences with $27.3M Investment in Private Placement and Open Market Buys
- Solid Biosciences Secures $240M Private Placement, Extends Cash Runway Amid Significant Dilution
- Solid Biosciences Secures $240M Oversubscribed Private Placement
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$174.32M
Diluted EPS
-$1.99
Op. Cash Flow
-$156.29M
Free Cash Flow
-$157.44M
Operating Income
-$179.21M
Cash & Equivalents
$59.9M
Debt / Equity
0.00×
Shares Outstanding
78.97M sh
Source: 10-K · filed 2026-03-19 · accession 0001193125-26-115928
show_chartPrice Chart
Loading chart...
feed SLDB - Filings & News (Page 2)
SLDB
Mar 10, 2026, 4:38 PM EDT
Price at Filing:
$8.25
Real-time Price:
$6.25
Change:
-$2.00 (-24%)
Market Cap:
$697.566M
SLDB
Mar 06, 2026, 4:36 PM EST
Price at Filing:
$6.85
Real-time Price:
$6.25
Change:
-$0.600 (-9%)
Market Cap:
$697.566M
SLDB
Mar 06, 2026, 8:32 AM EST
Price at Filing:
$6.22
Real-time Price:
$6.25
Change:
+$0.030 (+0.48%)
Market Cap:
$697.566M